Approval · Notice of Compliance 5233 · 1995
PROTROPIN: Notice of Compliance 5233
Issued December 28, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5233
- Date
- December 28, 1995
- Company
- Genentech IncS.San Francisco, California, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New disage regimen (daily), new route of administration (subcutaneous)
- Therapeutic class
- Growth stimulant